Style | Citing Format |
---|---|
MLA | Boroumand AB, et al.. "Immunogenicity of Covid-19 Vaccines in Patients With Diabetes Mellitus: A Systematic Review." Frontiers in Immunology, vol. 13, no. , 2022, pp. -. |
APA | Boroumand AB, Forouhi M, Karimi F, Moghadam AS, Naeini LG, Kokabian P, Naderi D (2022). Immunogenicity of Covid-19 Vaccines in Patients With Diabetes Mellitus: A Systematic Review. Frontiers in Immunology, 13(), -. |
Chicago | Boroumand AB, Forouhi M, Karimi F, Moghadam AS, Naeini LG, Kokabian P, Naderi D. "Immunogenicity of Covid-19 Vaccines in Patients With Diabetes Mellitus: A Systematic Review." Frontiers in Immunology 13, no. (2022): -. |
Harvard | Boroumand AB et al. (2022) 'Immunogenicity of Covid-19 Vaccines in Patients With Diabetes Mellitus: A Systematic Review', Frontiers in Immunology, 13(), pp. -. |
Vancouver | Boroumand AB, Forouhi M, Karimi F, Moghadam AS, Naeini LG, Kokabian P, et al.. Immunogenicity of Covid-19 Vaccines in Patients With Diabetes Mellitus: A Systematic Review. Frontiers in Immunology. 2022;13():-. |
BibTex | @article{ author = {Boroumand AB and Forouhi M and Karimi F and Moghadam AS and Naeini LG and Kokabian P and Naderi D}, title = {Immunogenicity of Covid-19 Vaccines in Patients With Diabetes Mellitus: A Systematic Review}, journal = {Frontiers in Immunology}, volume = {13}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Boroumand AB AU - Forouhi M AU - Karimi F AU - Moghadam AS AU - Naeini LG AU - Kokabian P AU - Naderi D TI - Immunogenicity of Covid-19 Vaccines in Patients With Diabetes Mellitus: A Systematic Review JO - Frontiers in Immunology VL - 13 IS - SP - EP - PY - 2022 ER - |